AI assistant
MACROGENICS INC — Director's Dealing 2024
May 23, 2024
34129_dirs_2024-05-23_252fba0c-00f2-4611-a349-24cf8506d16a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-05-21
Reporting Person: Chhabra Meenu (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-21 | Restricted Stock Unit | $0 | A | 6500 | Acquired | Common Stock (6500) | Direct | |
| 2024-05-21 | Stock Option (right to buy) | $4.26 | A | 16500 | Acquired | 2034-05-21 | Common Stock (16500) | Direct |
| 2024-05-21 | Stock Option (right to buy) | $4.26 | A | 17077 | Acquired | 2034-05-21 | Common Stock (17077) | Direct |
Footnotes
F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F2: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
F3: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F4: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.